NDSIB
GILD icon

North Dakota State Investment Board’s Gilead Sciences GILD Stock Holding History

North Dakota State Investment Board’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68M Sell
37,032
-1,655
-4% -$218K 0.19% 79
2026
Q1 		$5.39M Sell
38,687
-6,774
-15% -$949K 0.23% 62
2025
Q4 		$5.58M Buy
+45,461
New +$5.52M 0.21% 74

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

North Dakota State Investment Board's GILD Position: Q2 2026 in Review

North Dakota State Investment Board reduced its Gilead Sciences (GILD) stake by 4.3% in Q2 2026, selling an estimated $218K and leaving 37,032 shares worth $4.68M. The position accounts for 0.19% of the portfolio, ranked #79.

North Dakota State Investment Board first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.58M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • North Dakota State Investment Board held 37,032 shares of Gilead Sciences worth $4.68M as of Q2 2026.
  • North Dakota State Investment Board sold 1,655 Gilead Sciences shares in Q2 2026, an estimated $218K.
  • Gilead Sciences made up 0.19% of North Dakota State Investment Board's portfolio in Q2 2026, its #79 holding.
  • North Dakota State Investment Board first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's Gilead Sciences position peaked at $5.58M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.